Avinger to Announce Fourth Quarter and Full Year 2016 Results on March 6, 2017
February 21, 2017 16:01 ET
|
Avinger Inc
REDWOOD CITY, Calif., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today announced that it will...
Avinger Announces 24-Month Outcomes from the Pivotal VISION Study of Lumivascular Technology for Peripheral Artery Disease
January 25, 2017 16:01 ET
|
Avinger Inc
REDWOOD CITY, Calif. and LEIPZIG, Germany, Jan. 25, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today...
Avinger Announces Presentations Showcasing Lumivascular Technology at Leipzig Interventional Course
January 19, 2017 16:01 ET
|
Avinger Inc
REDWOOD CITY, Calif., Jan. 19, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced a schedule of...
Avinger Announces Preliminary Fourth Quarter 2016 Results
January 06, 2017 07:30 ET
|
Avinger Inc
REDWOOD CITY, Calif., Jan. 06, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today announced that based on...
Avinger Announces New FDA Clearance for Lumivascular Imaging Console, Enabling Vessel Measurement Via Touchscreen
December 22, 2016 07:30 ET
|
Avinger Inc
Technology Upgrade to Lightbox L250 Allows Physicians to Accurately Assess Luminal Gain REDWOOD CITY, Calif., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of...
Avinger Announces Third Quarter 2016 Results
November 03, 2016 16:01 ET
|
Avinger Inc
REDWOOD CITY, Calif., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today...
Avinger to Present at Upcoming Investor Conferences
October 27, 2016 16:01 ET
|
Avinger Inc
REDWOOD CITY, Calif., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the Company...
Avinger Launches Upgraded Lightbox Imaging Console
October 25, 2016 16:01 ET
|
Avinger Inc
REDWOOD CITY, Calif., Oct. 25, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the U.S....
Avinger to Announce Third Quarter 2016 Results on Thursday, November 3, 2016
October 24, 2016 16:01 ET
|
Avinger Inc
REDWOOD CITY, Calif., Oct. 24, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will...
Avinger Announces Schedule of Sessions Highlighting Lumivascular Technology at TCT 2016
October 20, 2016 16:01 ET
|
Avinger Inc
REDWOOD CITY, Calif., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced a schedule of...